The registration for this event has reached capacity and is CURRENTLY CLOSED.
We look forward to seeing everyone in New York City!

Call the registration line if you have any questions regarding the status of the course.

ADVANCED CME SYMPOSIUM

This advanced continuing medical education activity, to be held at the historic Hudson Theatre at Millennium Broadway, will provide participants with state-of-the-art education and practical guidance from nationally and internationally recognized experts on hepatitis C virus infection.

The primary goals of this activity are to increase each frontline care provider's competence in:

• » Evaluation of the natural history of hepatitis C
• » Assessment of disease stage and prognosis
• » Awareness of new therapeutic drugs, their appropriate use and potential side-effects
• » Formulation of individualized plans of care



TARGET AUDIENCE

The state-of-the art curriculum offered at this activity is designed for hepatologists, gastroenterologists, infectious disease specialists, HIV specialists, general practitioners, physician assistants, nurse practitioners, registered nurses, pharmacists and other frontline healthcare professionals involved in management of patients with hepatitis C, including those with HCV-HIV coinfection.




OBJECTIVES

At the conclusion of this activity, participants should be able to:


• » Evaluate the natural history of hepatitis C and HCV-HIV coinfection
• » Diagnose HCV infection and its clinical complications
• » Assess hepatitis C disease stage and clinical complications
• » Develop patient-management strategies using novel therapies
• » Effectively manage treatment-naive and -experienced patients
• » Assess the potential for drug-drug interactions during therapy
• » Evaluate the potential for drug resistance
• » Manage patients with HCV-HIV coinfection
• » Manage HCV infection in special patient populations



As we enter the second year of HEPATITIS C MANAGEMENT: STATE OF THE ART, enormous progress is being made in treatment of this disease. A rapidly increasing number of treatment options requires practitioners to continually update their knowledge about the potential benefits and adverse effects of the various new types of hepatitis C therapy. These therapies and their side effects make the decision to treat individual patients more complex and require a sophisticated understanding of the natural history of the disease as well as drug metabolism and management of treatment complications in the various populations of patients with HCV infection.

This advanced continuing medical education activity will provide participants with the latest information and practical guidance from nationally and internationally recognized experts on epidemiology, pathogenesis, natural history, and treatment of HCV infection and its comorbidities, so that practitioners can deliver high quality care in all practice settings.